跳至主要内容
临床试验/NCT01807910
NCT01807910撤回早期 1 期

Phospholipid Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver Disease

Vanderbilt University1 个研究点 分布在 1 个国家开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
撤回
试验地点
1
主要终点
Net hepatic phospholipid production

研究概览

简要总结

The investigators overall hypothesis is that exacerbation of endoplasmic reticulum (ER) stress in the liver is associated with significant alterations in phosphatidylcholines that drive the NASH phenotype in obese humans. The investigators plan to examine this hypothesis in a well-characterized cohort of obese subjects that are scheduled for bariatric surgery. Methyl-D9-choline chloride will be infused before and after a 2-week high fructose or glucose feeding to determine the biosynthesis and kinetics of secretory lipoprotein phospholipids. It is proposed that phospholipid metabolism play an important role in the pathogenesis or etiology of fatty liver in non-alcoholic conditions through mechanisms that invoke ER and oxidative stress responses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Ambulatory females age 30-60 years old
  • Women of all ethnic groups
  • BMI≥35 kg/m2
  • Approval for Roux-en-Y gastric bypass or sleeve gastrectomy.

排除标准

  • Smoking >7 cigarettes per day
  • Previous malabsorptive or restrictive intestinal surgery
  • Pregnant or breastfeeding
  • Recent history of neoplasia (<5 years ago)
  • Malabsorptive syndromes
  • Inflammatory intestinal disease
  • Patients with established organ dysfunction
  • Diagnosis of type 1 or type 2 diabetes mellitus or current use of anti-diabetic medication (last 30 days; last 60days for thiazolidinediones)
  • Diagnosed hyperbetalipoproteinemia or hypobetalipoproteinemia
  • Patients on cholesterol lowering medicines
  • Vegan diet
  • Hepatic fat content <10% by MRI
  • Inability to comply with study protocol such as unable to make study visits or be available daily for phone contact
  • Any condition which would interfere with MRI or PET studies, e.g. claustrophobia, cochlear implant, chronic back pain limiting ability to lay flat, metal fragments in eyes, cardiac pacemaker, neural stimulator, tattoos with iron pigment and metallic body inclusions or other metal implanted in the body which may interfere with MRI scanning.

研究组 & 干预措施

Fructose

Experimental

Participants will receive fructose (3g/kg/day) for 2 weeks.

干预措施: methyl-D9-choline (Drug)

Glucose

Active Comparator

Participants will receive glucose (3g/kg/day) for 2 weeks.

干预措施: methyl-D9-choline (Drug)

结局指标

主要结局

Net hepatic phospholipid production

时间窗: Baseline and 2 weeks

Net hepatic phospholipid production will be determined using \[11C\]choline dynamic Positron Emission Tomography (PET) before and after high fructose feeding for two weeks. A similar group of control obese subjects will undergo the same procedures before and after two weeks isocaloric glucose feeding.

次要结局

  • Kinetics of secretory lipoprotein phospholipids(Baseline and 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Charles R. Flynn

Assistant Professor

Vanderbilt University

研究点 (1)

Loading locations...

相似试验